SCHEMBL20490716

SCHEMBL20490716

COc1cc(C2CCN(CC(C)(C)C(=O)O)CC2)c(C)cc1Nc1ncc(Cl)c(Nc2cccnc2S(=O)(=O)C(C)C)n1

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 20/20 0.65
▸ INSR P06213 9/20 0.65
▸ KCNH2 Q12809 3/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20490705 0.96 ALK (0.71) ALKINSRKCNH2
SCHEMBL20567274 0.89 ALK (0.66) ALKINSRKCNH2
SCHEMBL28427764 0.87 ALK (0.67) ALKINSRKCNH2
SCHEMBL20567914 0.84 ALK (0.73) ALKINSRKCNH2
SCHEMBL20490720 0.84 ALK (0.81) ALKINSRKCNH2
SCHEMBL25566496 0.81 ALK (0.90) ALKINSRKCNH2
SCHEMBL25566500 0.80 ALK (0.81) ALKINSRKCNH2
SCHEMBL25569248 0.79 ALK (0.77) ALKINSRKCNH2
SCHEMBL25566486 0.79 ALK (0.79) ALKINSRKCNH2
SCHEMBL25566006 0.79 ALK (0.90) ALKINSRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3372594-B1 PYRIMIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER HUMANWELL HEALTHCARE GROUP CO LTD (CN) 2021-07-21 — — EP disclosed
EP-3372594-A1 PYRIMIDINE DERIVATIVE AND USE THEREOF Humanwell Healthcare (Group) Co., Ltd. (CN) 2018-09-12 — — EP disclosed
Send feedback